Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors
During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect patient safety and ensure data integrity. This notice addresses the concerns of clinical trial sponsors and Canadians.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsorsHTMLEnglish publication HTML